跳至主要内容
临床试验/IRCT20161207031288N9
IRCT20161207031288N9招募中2 期

Clinical study of topical nanoliposome formulation of ruxolitinib 1.5% in treatment of mild to moderate atopic dermatitis

Tehran University of Medical Sciences0 个研究点目标入组 20 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • Case of mild to moderate atopic dermatitis (SCORAD between 4 and 12)
  • Older than 18 years
  • Signing informed consent to participate in the study
  • Having a negative pregnancy test
  • Willingness to actively participate in the study

排除标准

  • Pregnancy and lactation
  • Use of any topical corticosteroids in the last 14 days
  • Drug and alcohol addiction
  • Use of oral corticosteroids or other immunosuppressive drugs in the last 28 days

研究者

相似试验

Clinical study of topical nanoliposome formulation... | 临床试验